http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5179090-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c12e746b4c00f9d9affcc8d736fab73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b829cb3d59f6ae3cf381bf2e9599bb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_200b2a30711f81e8cac6816113edd610 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53dfb7cea0dc6fce8b17f3a9c15be250 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766a603d43bc664d54cb2080bcb8b670 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6abbea5d02aaf3b2d85ae8c17bb14aca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffcf17848235b6127d390775c3ea06d9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
filingDate | 1991-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1993-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12ff4807855f48934b260b855799e75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690de48a2d1906500662396ce5562292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba090f4b56df599c56bf8073786af45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc81c86691976509e127d81251d1599b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431e612673b5e9cd87a629175ed6efcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df01b77e81e3681be90e9d208da884a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a948b7be6ef05ca6dfbe65d179fd843e |
publicationDate | 1993-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-5179090-A |
titleOfInvention | Condensed diazepinones and medicaments containing these compounds |
abstract | Condensed diazepinones of general formula I <IMAGE> (I) in which ]+E,crc/B/ represents one of the divalent groups <IMAGE> (S) <IMAGE> (T) <IMAGE> (U) <IMAGE> (V) X is a =CH- group or a nitrogen atom, R represents a lower alkyl radical, which may optionally be further substituted by a phenyl optionally carrying halogen, methyl or methoxy, R4 and R5 represent hydrogen, halogen or lower alkyl, R6 is hydrogen, chlorine or methyl, R7 and R8 denote lower alkyl, R8 also additionally denotes halogen, and m, n, o and p represent the numbers 0, 1, 2 or 3 with the following limitations: the sum of m+n and the sum of o+p each denote the numbers 1, 2 or 3, the sum of n+o and the sum of m+p each denote the numbers 1, 2, 3, 4 or 5, wherein, however, the sum of m+n+o+p must always be greater than 2, and A1, A2, A3 and A4 denote hydrogen, or, for the case where m, n, o and p each denote the number 1, A1 and A2 together or A3 and A4 together represent an ethylene bridge, are suitable for the treatment of cholinergically induced spasms and motility disorders of the gastrointestinal tract and in the region of the evacuating bile ducts, for the symptomatic treatment of cystitis and of spasms from urelithiasis, for the treatment of relative incontinence, for the symptomatic treatment of bronchial asthma and bronchitis, and for the treatment of ischaemic heart diseases. The compounds are characterized by good selectivity. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104402891-A |
priorityDate | 1989-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 456.